Castle Biosciences Inc
CSTL15.320USD
+0.670+4.57%
Close 08/04, 16:00（ET）Quotes delayed by 15 min
441.90MMarket Cap
LossP/E TTM
More Details of Castle Biosciences Inc Company
Castle Biosciences, Inc. is a commercial-stage diagnostics company. The Company is focused on providing physicians and their patients with personalized, clinically actionable information to clinicians and their patients to inform treatment decisions and improve health outcomes. Its portfolio consists of tests for skin cancers, uveal melanoma, Barretts esophagus and mental health conditions. Its products include DecisionDx-Melanoma, DecisionDx-SCC, MyPath Melanoma, TissueCypher, and DecisionDx-UM, IDgenetix. DecisionDx-Melanoma is a risk stratification gene expression profile (GEP) test that predicts the risk of metastasis, or recurrence, for patients diagnosed with invasive cutaneous melanoma (CM), a deadly skin cancer. MyPath Melanoma is GEP test offering for patients with difficult-to-diagnose melanocytic lesions. IDgenetix is pharmacogenomics (PGx) test that helps to guide optimal drug treatment for patients diagnosed with major depressive disorder, bipolar disorder, and other.
Company Info
Ticker SymbolCSTL
Company nameCastle Biosciences Inc
IPO dateJul 25, 2019
CEOMr. Derek J. Maetzold
Number of employees761
Security typeOrdinary Share
Fiscal year-endJul 25
Address505 S Friendswood Drive
CityFRIENDSWOOD
Stock exchangeNASDAQ Global Market Consolidated
CountryUnited States of America
Postal code77546
Phone18667889007
Websitehttps://castlebiosciences.com/
Ticker SymbolCSTL
IPO dateJul 25, 2019
CEOMr. Derek J. Maetzold
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Derek J. Maetzold
Mr. Derek J. Maetzold
President, Chief Executive Officer, Founder, Director
President, Chief Executive Officer, Founder, Director
361.91K
-1.35%
Ms. Kristen M. Oelschlager
Ms. Kristen M. Oelschlager
Chief Operating Officer
Chief Operating Officer
163.96K
+7.62%
Mr. Tobin W. (Toby) Juvenal
Mr. Tobin W. (Toby) Juvenal
Chief Commercial Officer
Chief Commercial Officer
80.41K
+11.41%
Mr. Frank Stokes
Mr. Frank Stokes
Chief Financial Officer
Chief Financial Officer
43.33K
+22.68%
Ms. Ellen Goldberg
Ms. Ellen Goldberg
Independent Director
Independent Director
27.25K
+46.68%
Mr. Miles D. Harrison
Mr. Miles D. Harrison
Independent Director
Independent Director
21.96K
+65.25%
Mr. Rodney Cotton
Mr. Rodney Cotton
Independent Director
Independent Director
19.33K
+81.38%
Ms. Tiffany P. Olson
Ms. Tiffany P. Olson
Independent Director
Independent Director
--
--
Ms. Kimberlee S. Caple
Ms. Kimberlee S. Caple
Independent Director
Independent Director
--
--
Mr. Daniel Mark (Dan) Bradbury
Mr. Daniel Mark (Dan) Bradbury
Independent Chairman of the Board
Independent Chairman of the Board
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Derek J. Maetzold
Mr. Derek J. Maetzold
President, Chief Executive Officer, Founder, Director
President, Chief Executive Officer, Founder, Director
361.91K
-1.35%
Ms. Kristen M. Oelschlager
Ms. Kristen M. Oelschlager
Chief Operating Officer
Chief Operating Officer
163.96K
+7.62%
Mr. Tobin W. (Toby) Juvenal
Mr. Tobin W. (Toby) Juvenal
Chief Commercial Officer
Chief Commercial Officer
80.41K
+11.41%
Mr. Frank Stokes
Mr. Frank Stokes
Chief Financial Officer
Chief Financial Officer
43.33K
+22.68%
Ms. Ellen Goldberg
Ms. Ellen Goldberg
Independent Director
Independent Director
27.25K
+46.68%
Mr. Miles D. Harrison
Mr. Miles D. Harrison
Independent Director
Independent Director
21.96K
+65.25%
Revenue Breakdown
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
No Data
By RegionUSD
Name
Revenue
Proportion
United States
87.99M
0.00%
By Business
By Region
No Data
Shareholding Stats
Updated: Sun, Jul 27
Updated: Sun, Jul 27
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
8.01%
The Vanguard Group, Inc.
7.07%
Portolan Capital Management, L.L.C.
5.58%
Principal Global Investors (Equity)
5.08%
Dimensional Fund Advisors, L.P.
4.16%
Other
70.09%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
8.01%
The Vanguard Group, Inc.
7.07%
Portolan Capital Management, L.L.C.
5.58%
Principal Global Investors (Equity)
5.08%
Dimensional Fund Advisors, L.P.
4.16%
Other
70.09%
Shareholder Types
Shareholders
Proportion
Investment Advisor
37.18%
Investment Advisor/Hedge Fund
35.28%
Hedge Fund
15.91%
Individual Investor
2.91%
Research Firm
2.85%
Pension Fund
0.97%
Bank and Trust
0.48%
Venture Capital
0.07%
Corporation
0.05%
Other
4.30%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
403
27.71M
95.98%
-3.07M
2025Q1
423
27.42M
95.08%
-3.59M
2024Q4
413
27.81M
97.60%
-2.39M
2024Q3
414
27.79M
100.23%
-3.05M
2024Q2
400
27.44M
99.43%
-4.42M
2024Q1
407
28.20M
102.27%
-5.76M
2023Q4
407
26.80M
99.62%
-6.63M
2023Q3
416
26.10M
97.38%
-6.68M
2023Q2
414
24.88M
93.24%
-6.39M
2023Q1
420
24.03M
90.08%
-9.68M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
2.31M
8.01%
+53.08K
+2.35%
Mar 31, 2025
The Vanguard Group, Inc.
2.04M
7.07%
+215.03K
+11.77%
Mar 31, 2025
Portolan Capital Management, L.L.C.
1.61M
5.58%
+345.88K
+27.34%
Apr 07, 2025
Principal Global Investors (Equity)
1.47M
5.08%
+32.21K
+2.24%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
1.20M
4.16%
+200.76K
+20.09%
Mar 31, 2025
Wasatch Global Investors Inc
998.46K
3.46%
-797.63K
-44.41%
Mar 31, 2025
Wellington Management Company, LLP
828.53K
2.87%
+106.41K
+14.74%
Mar 31, 2025
Nuveen LLC
723.60K
2.51%
+369.89K
+104.57%
Mar 31, 2025
State Street Global Advisors (US)
715.03K
2.48%
+4.82K
+0.68%
Mar 31, 2025
Renaissance Technologies LLC
701.20K
2.43%
+16.20K
+2.36%
Mar 31, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
SPDR S&P Health Care Services ETF
1.13%
Harbor Human Capital Factor US Small Cap ETF
0.27%
Royce Quant Small-Cap Quality Value ETF
0.25%
Inspire Small/Mid Cap ESG ETF
0.2%
iShares Micro-Cap ETF
0.13%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.11%
iShares U.S. Healthcare Providers ETF
0.09%
Avantis US Small Cap Equity ETF
0.07%
Invesco Nasdaq Biotechnology ETF
0.07%
Goldman Sachs Innovate Equity ETF
0.07%
View more
SPDR S&P Health Care Services ETF
Proportion1.13%
Harbor Human Capital Factor US Small Cap ETF
Proportion0.27%
Royce Quant Small-Cap Quality Value ETF
Proportion0.25%
Inspire Small/Mid Cap ESG ETF
Proportion0.2%
iShares Micro-Cap ETF
Proportion0.13%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proportion0.11%
iShares U.S. Healthcare Providers ETF
Proportion0.09%
Avantis US Small Cap Equity ETF
Proportion0.07%
Invesco Nasdaq Biotechnology ETF
Proportion0.07%
Goldman Sachs Innovate Equity ETF
Proportion0.07%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
